HCW Biologics issues 126,000 shares upon Armistice warrant exercise

HCW Biologics Inc.

Issued 126,000 common shares to Armistice Capital Master Fund on May 22, 2025 upon exercise of pre-funded warrants at $0.0001/share.
Remaining pre-funded warrants held by Armistice cover 210,000 shares as of May 22, 2025.
This is the second exercise tranche; 177,140 shares were issued on May 15, 2025 from the same warrants.
Exercise generates negligible proceeds to the company due to $0.0001 per share exercise price.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.